The FTSE 100’s record run was poised to come to an end on Wednesday as pharma stocks slumped on the back of a controversial US regulatory appointment. The blue-chip index was down 0.3 per cent in mid-morning trading. Drugmakers GSK and Astrazeneca were among the top fallers, at nearly four per cent and two per [...]
Full ArticleFTSE 100’s record run fades as pharma stocks slide on new Trump appointment
City A.M.
0 shares
1 views